Alix Ventures
Alix Ventures: Driving Patient Impact - Supporting Early Stage Life Science Startups Engineering Biology to Drive Radical Advances in Human Health Born from our collective experience as founders, we set out to build the fund we wanted to raise from... Thesis: Life Sciences is experiencing rapid innovation with the rise of TechBio, a change we believe is leading to some of the most impactful solutions in decades. Our passion is to help build transformative companies ahead of this revolution to significantly impact the quality & effectiveness of patient care. We aim to partner with passionate, accomplished founders who possess unique insights to solve some of the world’s most daring problems facing us in Life Sciences. Team: Our entire team is composed of serial VC backed Life Sciences founders with experience in raising capital, scaling teams, running labs, navigating regulatory mazes, partnering with pharma & the many fires that consist of operating an early stage company. We’ve been in your shoes before, we pride ourselves in being the VC we wish we had on our own cap tables, founders we are here to help! SAB/MAB: Composed of top VC-backed PhD Life Sciences founders, our scientific & medical advisory board aids our investment team in both technical & clinical diligence - thus providing a multitude of expertise & fluency across a wide variety of Life Science sub-domains. Let’s talk science! Support: Helping our founders is our utmost priority. To tackle the many challenges ahead, we’ve curated a full platform of resources to help with customer introductions, fundraising, & team building, amongst others. In addition, dedicated to supporting our portfolio is our operating partner - Mark Pulido (5x HC/LS CEO - previously of Novartis, McKesson, & Ability) & our extensive network of industry executives spanning Top 25 Pharma, major health systems, & large payors. Limited Partners: Anchored by leading strategic LPs making up some of the best venture capital firms in the world, veteran founders, & industry experts. Alix is here to fill the void for early stage Life Sciences specific capital in Silicon Valley.
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.
Zafrens is a drug discovery company that develops life sciences products that allow full characterization of diverse cell populations. The company's platform specializes in generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States.
Pair Team is on a mission to build the primary care infrastructure for vulnerable communities. They are the first tech-enabled care team that empowers safety-net primary care systems and the Medicaid & Medicare patients they serve. They act as an extension of the clinical staff to provide a personalized, high-touch care experience while addressing patients' barriers to care such as lack of transportation, housing/food insecurity, and mobile phone access. Internally, they are building a unique care delivery platform to ensure clinical best practices, integrate care with community-based organizations, and automate administrative work so clinicians can focus on patient time.
Zafrens is a drug discovery company that develops life sciences products that allow full characterization of diverse cell populations. The company's platform specializes in generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States.
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response. The company was founded in 2020 and is based in Salt Lake City, Utah.
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.
Elegen is a biotechnology company that develops microfluidic technology. It is driven by a mission to deploy this technology in a new generation of DNA synthesizers aimed at enabling and accelerating biomedical advances. The company was founded in 2017 and led by Dr. Matthew Hill.
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.
Circularis Biotechnologies develops a revolutionary technology to regulate gene expression and enable increased biotherapeutic production. It was founded in 2014 and is headquartered in Oakland, California.
Pair Team is on a mission to build the primary care infrastructure for vulnerable communities. They are the first tech-enabled care team that empowers safety-net primary care systems and the Medicaid & Medicare patients they serve. They act as an extension of the clinical staff to provide a personalized, high-touch care experience while addressing patients' barriers to care such as lack of transportation, housing/food insecurity, and mobile phone access. Internally, they are building a unique care delivery platform to ensure clinical best practices, integrate care with community-based organizations, and automate administrative work so clinicians can focus on patient time.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.